Soleno Therapeutics Presents Clinical Data on DCCR at Late-Breaking Session of European Society for Paediatric Endocrinology
Pharmacokinetic data supports once-daily dosing Long-term use of DCCR not associated with compromised glycemic control REDWOOD CITY, Calif., Oct. 01, 2018 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (NASDAQ:SLNO), a clinical-stage biopharmaceutical …